Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Sarcoma, Kaposi × Nelfinavir × Clear all

Phase

Phase 2 3 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1 Head & Neck 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Sarcoma, Kaposi 1 Sarcoma 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Hodgkin Disease 1 Castleman Disease 1

Interventions

Nivolumab 1 Nelfinavir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02080416 2016-06-10

Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase EARLY_PHASE1 Terminated

GastrointestinalHead & NeckLymphoidSarcoma

Castleman Disease, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Nasopharyngeal Neoplasms, Neoplasms, Sarcoma, Sarcoma, Kaposi, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡